ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2022

Neoadjuvant versus definitive radiochemotherapy of locoregionally advanced oesophageal cancer-who benefits?

Christoph Schiffner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.